FMR LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
FMR LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$642,769
-8.2%
70,479
+6.5%
0.00%
Q2 2023$700,016
-29.9%
66,164
-19.0%
0.00%
Q1 2023$998,926
+104.5%
81,678
+107.5%
0.00%
Q4 2022$488,435
-46.5%
39,358
-41.1%
0.00%
Q3 2022$913,000
-24.8%
66,823
+0.8%
0.00%
Q2 2022$1,214,000
+13.5%
66,270
-0.4%
0.00%
Q1 2022$1,070,000
-98.6%
66,548
-98.8%
0.00%
-100.0%
Q4 2021$78,151,000
-33.0%
5,582,200
-10.3%
0.01%
-33.3%
Q3 2021$116,589,000
-28.3%
6,224,773
-20.2%
0.01%
-30.8%
Q2 2021$162,713,000
-37.3%
7,803,975
-15.0%
0.01%
-40.9%
Q1 2021$259,503,000
-12.8%
9,179,469
+0.7%
0.02%
-15.4%
Q4 2020$297,730,000
+34.2%
9,116,040
+25.9%
0.03%
+18.2%
Q3 2020$221,809,000
+68.3%
7,239,188
-10.5%
0.02%
+57.1%
Q2 2020$131,780,000
+94.4%
8,084,683
+18.6%
0.01%
+55.6%
Q1 2020$67,801,000
-27.5%
6,814,206
+0.3%
0.01%
-10.0%
Q4 2019$93,462,000
-8.5%
6,797,202
+1.0%
0.01%
-16.7%
Q3 2019$102,139,000
+6.5%
6,732,989
+38.2%
0.01%
+9.1%
Q2 2019$95,908,000
+213.2%
4,870,878
+163.9%
0.01%
+175.0%
Q1 2019$30,625,000
-4.6%
1,846,010
-19.2%
0.00%0.0%
Q4 2018$32,089,000
-19.8%
2,285,5100.0%0.00%0.0%
Q3 2018$39,996,000
-34.7%
2,285,510
-32.1%
0.00%
-42.9%
Q2 2018$61,269,000
-26.3%
3,366,419
-24.1%
0.01%
-30.0%
Q1 2018$83,128,000
+161.1%
4,433,515
+113.0%
0.01%
+150.0%
Q4 2017$31,842,000
-17.7%
2,081,171
-19.6%
0.00%
-20.0%
Q3 2017$38,674,000
+47.7%
2,586,919
-8.1%
0.01%
+66.7%
Q2 2017$26,188,000
+5.7%
2,815,9190.0%0.00%0.0%
Q1 2017$24,780,000
+49.2%
2,815,9190.0%0.00%
+50.0%
Q4 2016$16,614,000
-5.6%
2,815,9190.0%0.00%0.0%
Q3 2016$17,599,000
+130.6%
2,815,9190.0%0.00%
+100.0%
Q2 2016$7,631,000
-39.2%
2,815,919
-9.1%
0.00%
-50.0%
Q1 2016$12,544,000
-52.0%
3,097,354
-0.5%
0.00%
-50.0%
Q4 2015$26,155,0003,113,7190.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders